CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5.Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Ease in the cultivation of marine organisms
4.1.2. Reduced automation complexity
4.1.3. Increase in adoption of subs among various companies
4.2.Market Restraints & Challenges
4.2.1. Need for improved single-use sensors
4.2.2. Issues regarding leachables and extractables
4.3. Market Opportunities
4.3.1. Growing biologics markets
CHAPTER 5. GLOBAL SINGLE USE BIOREACTORS MARKET– BY TYPE
5.1. Introduction
5.2. Bubble-Column Single-Use Bioreactor
5.3. Stirred-Tank Single-Use Bioreactor
5.4. Wave-Induced Single-Use Bioreactor
5.5. Other Single-Use Bioreactor
CHAPTER 6. GLOBAL SINGLE USE BIOREACTORS MARKET – BY PRODUCT
6.1. Introduction
6.2. Single-Use Bioreactor Systems
6.2.1. Up to 10l
6.2.2. 11–100l
6.2.3. 101–500l
6.2.4. 501–1500l
6.2.5. Above 1500l
6.3. Media Bags
6.3.1. 2D Bags
6.3.2. 3D Bags
6.3.3. Other Media Bags
6.4. Filtration Assemblies
6.5. Other Products
CHAPTER 7. GLOBAL SINGLE USE BIOREACTORS MARKET – BY TYPE OF
CELL
7.1. Introduction
7.2. Mammalian Cells
7.3. Bacterial Cells
7.4. Yeast Cells
7.5. Other Cells
CHAPTER 8. GLOBAL SINGLE USE BIOREACTORS MARKET – BY TYPE OF
MOLECULE
8.1. Introduction
8.2. Monoclonal Antibodies (MABS)
8.3. Vaccines
8.4. Stem Cells
8.5. Gene-Modified Cells
8.6. Other Molecules
CHAPTER 9. GLOBAL SINGLE USE BIOREACTORS MARKET – BY
APPLICATION
9.1. Introduction
9.2. Research & Development
9.3. Process Development
9.4. Bioproduction
CHAPTER 10. GLOBAL SINGLE USE BIOREACTORS MARKET - BY GEOGRAPHY
10.1. Introduction
10.2.North America
10.2.1. The U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL SINGLE USE BIOREACTORS MARKET - COMPANY
PROFILES
11.1. Pierre Guerin
11.2. Cesco Bioengineering Co., Ltd.
11.3. GE Healthcare
11.4. Danaher
11.5. Applikon Biotechnology
11.6. Parker Hannifin
11.7. Sartorius Stedim Biotech SA
11.8. Eppendorf
11.9. Thermo Fisher Scientific
11.10. Cellexus
11.11. Celltainer Biotech
11.12. PBS Biotech
11.13. Distek, Inc.
11.14. Solida Biotech
11.15. Merck Millipore
CHAPTER 12. GLOBAL SINGLE USE BIOREACTORS MARKET - COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
